Literature DB >> 30864273

In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion.

Qi Da1,2, Hyojeong Han2,3, Christian Valladolid1,2,4, María Fernández1,2, Tanvir Khatlani1,2, Subhashree Pradhan1,2, Jennifer Nolasco1,2, Risë K Matsunami5, David A Engler5, Miguel A Cruz1,2,3,4, K Vinod Vijayan1,2,3,4.   

Abstract

Essentials Platelet adhesion to von Willebrand factor (VWF) is critical for hemostasis and thrombosis. Whether VWF can undergo phosphorylation is unknown. Family with sequence similarity 20 kinase phosphorylates VWF A2 domain at S1517 and S1613. Phosphorylation of VWF and VWF A1A2A3 domain at S1613 enhances platelet adhesion.
SUMMARY: Background von Willebrand factor (VWF) mediates platelet adhesion and contributes to hemostasis at sites of vascular injury as well as to arterial thrombosis. The A1A2A3 domains of VWF contain important sites that differentially participate in supporting platelet adhesion. FAM20c (family with sequence similarity 20, member C) has emerged as a serine/threonine kinase, which phosphorylates extracellular proteins containing the S-X-E/pS motifs that are also found within the VWF A domains. This is of interest because we and others have shown that structural modifications within these A domains influence the ability of VWF to support platelet adhesion. Objective We assessed if VWF A domains can be phosphorylated and the functional consequence of phosphorylated VWF. Results Here, we show that FAM20c phosphorylated purified plasma VWF, VWF A1A2A3 protein, isolated A2 domain, but not A1 and A3 domain proteins, in vitro. FAM20c phosphorylated the isolated A2 domain at S1517 and S1613 within the S-X-E recognition motif, with S1613 being the major phosphorylation site. Mass spectrometry analysis of purified plasma VWF from healthy donors revealed several phosphorylation sites, including the S1613 in the A2 domain. VWF A1A2A3 domain protein phosphorylated at S1613 promoted stable platelet adhesion and microthrombi at high shear stress. Lastly, under high shear stress VWF treated with FAM20c and ATP robustly supported platelet adhesion, compared to VWF treated with FAM20c in the absence of ATP. Conclusion These outcomes indicate that VWF can be phosphorylated by FAM20c in vitro, and this novel post-translational modification enhances the adhesiveness of VWF to platelets.
© 2019 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  blood platelets; cell adhesion; phosphorylation; protein kinase; von Willebrand factor

Mesh:

Substances:

Year:  2019        PMID: 30864273      PMCID: PMC6545126          DOI: 10.1111/jth.14426

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

1.  Characterization of the human cerebrospinal fluid phosphoproteome by titanium dioxide affinity chromatography and mass spectrometry.

Authors:  Justyna Maria Czarna Bahl; Søren Skov Jensen; Martin R Larsen; Niels H H Heegaard
Journal:  Anal Chem       Date:  2008-08-15       Impact factor: 6.986

2.  Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells.

Authors:  Arminja N Kettenbach; Devin K Schweppe; Brendan K Faherty; Dov Pechenick; Alexandre A Pletnev; Scott A Gerber
Journal:  Sci Signal       Date:  2011-06-28       Impact factor: 8.192

3.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

4.  Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides.

Authors:  M A Cruz; H Yuan; J R Lee; R J Wise; R I Handin
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

5.  ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate.

Authors:  J L Whitelock; L Nolasco; A Bernardo; J Moake; J-F Dong; M A Cruz
Journal:  J Thromb Haemost       Date:  2004-03       Impact factor: 5.824

6.  Phosphorylation in vitro of fibrinogen from three mammalian species with four different protein kinases.

Authors:  E Humble; P Heldin; P O Forsberg; L Engström
Journal:  Arch Biochem Biophys       Date:  1985-08-15       Impact factor: 4.013

7.  Phosphorylation of factor Va and factor VIIIa by activated platelets.

Authors:  M Kalafatis; M D Rand; R J Jenny; Y H Ehrlich; K G Mann
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

8.  Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress.

Authors:  Qi Da; Molly Behymer; Juliana I Correa; K Vinod Vijayan; Miguel A Cruz
Journal:  Blood       Date:  2014-03-18       Impact factor: 22.113

9.  Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactions.

Authors:  Camilo Aponte-Santamaría; Volker Huck; Sandra Posch; Agnieszka K Bronowska; Sandra Grässle; Maria A Brehm; Tobias Obser; Reinhard Schneppenheim; Peter Hinterdorfer; Stefan W Schneider; Carsten Baldauf; Frauke Gräter
Journal:  Biophys J       Date:  2015-05-05       Impact factor: 4.033

10.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations.

Authors:  Peter V Hornbeck; Bin Zhang; Beth Murray; Jon M Kornhauser; Vaughan Latham; Elzbieta Skrzypek
Journal:  Nucleic Acids Res       Date:  2014-12-16       Impact factor: 16.971

View more
  2 in total

Review 1.  The ABCs of the atypical Fam20 secretory pathway kinases.

Authors:  Carolyn A Worby; Joshua E Mayfield; Adam J Pollak; Jack E Dixon; Sourav Banerjee
Journal:  J Biol Chem       Date:  2021-01-08       Impact factor: 5.157

Review 2.  Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications.

Authors:  Rongsheng Xu; Huidan Tan; Jiahui Zhang; Zhaoxin Yuan; Qiang Xie; Lan Zhang
Journal:  Front Mol Biosci       Date:  2021-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.